(Q51485369)
Statements
Hepatic safety profile and glycemic control of pioglitazone in more than 20,000 patients with type 2 diabetes mellitus: postmarketing surveillance study in Japan. (English)
1 reference
Ryuzo Kawamori
1 reference
Takashi Kadowaki
1 reference
Morikazu Onji
1 reference
Yutaka Seino
1 reference
Yasuo Akanuma
1 reference
PRACTICAL Study Group
1 reference
15 November 2006
1 reference
76
1 reference
2
1 reference
229-235
1 reference